Pfizer STN 25 mg (Sutent 25 mg)
Generic Name: sunitinib
Pill imprint Pfizer STN 25 mg has been identified as Sutent 25 mg.
Sutent is used in the treatment of renal cell carcinoma; gastrointestinal stromal tumor; pancreatic cancer and belongs to the drug classes multikinase inhibitors, VEGF/VEGFR inhibitors. There is positive evidence of human fetal risk during pregnancy. Sutent 25 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Generic Name:
- sunitinib
- Imprint:
- Pfizer STN 25 mg
- Strength:
- 25 mg
- Color:
- Brown & Orange
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Multikinase inhibitors
VEGF/VEGFR inhibitors - Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Pfizer U.S. Pharmaceuticals Group
- National Drug Code (NDC):
- 00069-0770
- Inactive Ingredients:
- mannitol
croscarmellose sodium
povidone k25
magnesium stearate
gelatin
titanium dioxide
ferric oxide red
ferric oxide yellow
ferrosoferric oxide
shellac
propylene glycol
sodium hydroxide
povidone
More about Sutent (sunitinib)
Consumer resources
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
